Explore more publications!
Healthy Living Maldives
Got News to Share?

Healthy Living Maldives: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthy Living Maldives.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on November 25, 2025

INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025
November 25, 2025

INVO Fertility Announces a 1:8 Reverse Stock Split Effective Pre-Market Opening on November 28, 2025

Indeterminate GlobeNewswire
BioStem Technologies Expands Product Access in Medicaid
November 25, 2025

BioStem Technologies Expands Product Access in Medicaid

Indeterminate GlobeNewswire
Foundation for Sarcoidosis Research Convenes Global Leaders for Landmark Clinic Alliance Meeting and Sarcoidosis Biomarker Summit
November 25, 2025

Foundation for Sarcoidosis Research Convenes Global Leaders for Landmark Clinic Alliance Meeting and Sarcoidosis Biomarker Summit

Indeterminate GlobeNewswire
Prenetics Announces Upcoming Conference Participation
November 25, 2025

Prenetics Announces Upcoming Conference Participation

Indeterminate GlobeNewswire
Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025

Palisade Bio to Present at the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
Oncotelic Therapeutics Inc. (OTCQB: OTLC) Anticipates Major Fair-Value Uptick Following New Independent JV Valuation
November 25, 2025

Oncotelic Therapeutics Inc. (OTCQB: OTLC) Anticipates Major Fair-Value Uptick Following New Independent JV Valuation

Indeterminate GlobeNewswire
LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment
November 25, 2025

LIXTE Biotechnology Acquires Liora Technologies’ Proprietary Proton Therapy Platform for Cancer Treatment

Indeterminate GlobeNewswire
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
November 25, 2025

Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025

Indeterminate GlobeNewswire
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
November 25, 2025

Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access

Indeterminate GlobeNewswire
Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program
November 25, 2025

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program

Indeterminate GlobeNewswire
Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences
November 25, 2025

Lexicon Pharmaceuticals to Participate in Two Upcoming December Investor Conferences

Indeterminate GlobeNewswire
PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025
November 25, 2025

PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025

Indeterminate GlobeNewswire
Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS
November 25, 2025

Biomerica’s inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS

Indeterminate GlobeNewswire
2X Solutions Achieves SOC 2 Type II and HIPAA Compliance
November 25, 2025

2X Solutions Achieves SOC 2 Type II and HIPAA Compliance

Indeterminate GlobeNewswire
Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®
November 25, 2025

Teva receives European Commission approvals for PONLIMSI® (denosumab) Biosimilar to Prolia® and DEGEVMA® (denosumab) Biosimilar to Xgeva®

Indeterminate GlobeNewswire
Nanox Engages with Althea France to Accelerate European Commercialization of Nanox.ARC System
November 25, 2025

Nanox Engages with Althea France to Accelerate European Commercialization of Nanox.ARC System

Indeterminate GlobeNewswire
Prime Medicine to Present at 8th Annual Evercore Healthcare Conference
November 25, 2025

Prime Medicine to Present at 8th Annual Evercore Healthcare Conference

Indeterminate GlobeNewswire
Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer
November 25, 2025

Daxor Fuels Growth with Three New Facility Adoptions and Deployment of Next-Generation BVA Analyzer

Indeterminate GlobeNewswire
Septerna to Participate in 8th Annual Evercore Healthcare Conference
November 25, 2025

Septerna to Participate in 8th Annual Evercore Healthcare Conference

Indeterminate GlobeNewswire
Aclaris Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
November 25, 2025

Aclaris Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions